Therapies

Paxlovid, Pfizer's anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken October 7, 2022.Wolfgang Rattay | ReutersThe National Institutes of Health said Monday it launched…

New York, USA, July 26, 2023 (GLOBE NEWSWIRE) -- Anti-CD279 (PD-1) Antibody Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 35+ Companies and Therapies | DelveInsight The prevalence of cancer has been rising over…

New York, USA, July 24, 2023 (GLOBE NEWSWIRE) -- Advanced Renal Cell Carcinoma Clinical Trial Pipeline Space Brims With Novel Emerging Therapies with Over 50 Key Companies Working in the Domain | DelveInsight The prevalence of renal…

Researchers have demonstrated that a transplant surgical procedure (called 'needle trauma') triggers a profound immune response and causes the death of most grafted dopamine neurons. They also found that co-transplantation of neuronal cell…

ROCKVILLE, Md. and PHILADELPHIA, July 10, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and…

Researchers from the University of Colorado Anschutz Medical Campus have identified a potential new immune checkpoint receptor that could lead to treatments for diseases such as lung and bowel cancer and autoimmune conditions including IBD.…

New York, USA, June 29, 2023 (GLOBE NEWSWIRE) -- Sepsis Market Size and Share to Grow by 2032, Examines DelveInsight | Key Companies Developing Therapies - Regeneron, Merck, Shionogi, Sentien Biotechnologies, Basilea, Vivacelle Bio,…

Using 3-D models of ovarian cancer tumors, scientists found differences in gene activity based on where a cell is in a tumor, demonstrating how a cell's location and environment in a cancerous tumor can strongly influence which genes are…

In the midst of a global opioid epidemic, a team of scientists is exploring natural killer (NK) cells as an alternative treatment for neuropathic pain. In an Opinion piece published June 27th in the journal Trends in Neurosciences, the…

Article content Gibco™ OncoPro™ Tumoroid Culture Medium Kit broadens access to clinically relevant patient-derived tumor models Article content CARLSBAD, Calif. — Thermo Fisher Scientific, the world leader in serving science, today…